Roche's XCELLigence System Designed To Reduce Animal Testing In Pharmaceutical Development BOTOX® is an important
medicine that over the last 15 years of clinical use has helped millions of patients with serious medical conditions worldwide. Pharmaceutical manufacturers using Clostridium botulinum toxin (BOTOX®) in
drugs are required by the Food and Drug Administration (FDA) in the United States and by other worldwide
health regulatory agencies to protect patients and consumers by assuring product safety and efficacy through animal testing and other methods.
Source: www.medicalnewstoday.comNational Association Of Chain Drug Stores Pushing For Separate Food, Drug Regulations The National Association of Chain Drug Stores has begun lobbying House Energy and Commerce Committee leaders' staff in opposition to stricter track-and-trace rules in the wake of the recent salmonella outbreak, CongressDaily reports. Committee Chair John Dingell (D-Mich.) recently released a revised version of the drug portion of an
Source: www.medicalnewstoday.comThe Changing Marketplace Of Antithrombotics: Better Than Cheaper? Next generation anticoagulant and antiplatelet agents have shown superiority over the current market leaders in clinical studies and are to challenge them before generics. The Business Intelligence firm La Merie S.L. reported in its most recent update of the Antithrombotics Competitor Pipeline that sales of the two leading antithrombotics enoxaparin and clopidogrel are rather being challenged by improved innovator
drugs than by cheaper generics.
Source: www.medicalnewstoday.comDrug Companies 'Quietly' Increasing Prices Of Some Medications By 100% Or More, USA Today Reports Drug makers increased the average wholesale price of 26 brand-name
drugs by 100% or more in a single cost adjustment last year, compared with comparable price increases for 15
drugs in 2004, according to University of Minnesota researchers, USA Today reports.
Source: www.medicalnewstoday.comIrish Medicines Formulary Edition 4 Now Published The Irish
Medicines Formulary (IMF), Edition 4, has now been published and distributed to registered GPs in fulltime practice in Ireland. Since it was first published in February 2007, IMF continues to grow to meet the needs of Irish
healthcare professionals. A major innovation in Edition 4 is the inclusion of Illness Definitions.
Source: www.medicalnewstoday.com
# posted by Network @ 7:00 PM
